F-group (family)
210.1.2.7 NAAA-beta
Ligands and drugs
27
Member domains
18
with ligand contacts (≤ 4 Å)
66.7% of members
4
with DrugDomain annotations
14.8% of members
4
with a DrugBank compound
14.8% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 210.1.2.7 belongs to X-group 210 Ntn/PP2C, which binds 7.8 ligand superclasses per 20 proteins, broader than 53% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 4 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 15 |
| CL | CHLORIDE ION | 13 |
| TON | 2-{2-[4-(1,1,3,3-TETRAMETHYLBUTYL)PHENOXY]ETHOXY}ETHANOL | 5 |
| WTF | [2-(ethylsulfonyl)phenyl][(2S)-4-(6-fluoro-1,3-benzothiazol-2-yl)-2-methylpiperazin-1-yl]methanone | 4 |
| HJA | (2S)-3-amino-2-{[(4-cyclohexylbutoxy)carbonyl]amino}propanethioic S-acid | 3 |
| SCN | THIOCYANATE ION | 2 |
| 27L | 4-(2,4,4-trimethylpentan-2-yl)phenol | 1 |
| Kmetal | POTASSIUM ION | 1 |
| MYR | MYRISTIC ACID | 1 |
| TRT | FRAGMENT OF TRITON X-100 | 1 |